ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 195 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,542,000 | -4.8% | 21,665 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $1,619,000 | +73.0% | 21,665 | +63.9% | 0.00% | 0.0% |
| Q4 2018 | $936,000 | -14.1% | 13,215 | +3.6% | 0.00% | 0.0% |
| Q3 2018 | $1,090,000 | +268.2% | 12,752 | +398.5% | 0.00% | – |
| Q2 2018 | $296,000 | +23.8% | 2,558 | -57.6% | 0.00% | – |
| Q3 2014 | $239,000 | -88.1% | 6,030 | -87.1% | 0.00% | -100.0% |
| Q2 2014 | $2,008,000 | -1.1% | 46,615 | -8.2% | 0.00% | +50.0% |
| Q1 2014 | $2,030,000 | – | 50,765 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 1,055,719 | $35,367,000 | 12.68% |
| GREAT POINT PARTNERS LLC | 828,253 | $27,746,000 | 5.70% |
| McClain Value Management LLC | 116,153 | $3,891,000 | 4.80% |
| Stonepine Capital Management, LLC | 231,913 | $7,769,000 | 4.63% |
| ARMISTICE CAPITAL, LLC | 228,000 | $7,638,000 | 1.81% |
| Opaleye Management Inc. | 90,000 | $3,015,000 | 1.78% |
| Matarin Capital Management, LLC | 257,268 | $8,618,478,000 | 0.97% |
| HAYS ADVISORY LLC | 116,939 | $3,917,000 | 0.87% |
| Granahan Investment Management | 496,025 | $16,617,000 | 0.57% |
| AlphaMark Advisors, LLC | 33,000 | $1,106,000 | 0.57% |